Abstract
Get full access to this article
View all access options for this article.
References
1.
Naranjo CA
,
Busto U
,
Sellers EM
, A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther 1981 ;30 :239 –45 .
2.
Oncken C
,
Gonzales D
,
Nides M
, Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation . Arch Intern Med 2006 ;166 :1571 –7 .
3.
Tonstad S
,
Tonnesen P
,
Hajek P
, Effect of maintenance therapy with varenicline on smoking cessation . JAMA 2006 ;296 :64 –71 .
4.
Kohen I
,
Kremen N.
Varenicline-induced manic episode in a patient with bipolar disorder . Am J Psychiatry 2007 ;164 :1269 –70 .
5.
Freedman R.
Exacerbation of schizophrenia by varenicline . Am J Psychiatry 2007 :164 :1269 .
6.US Food and Drug Administration : MedWatch.www.fda.gov/medwatch/safety/2007/safety07.htm#Chantix (accessed 2008 Jan 4).